November 20,2007
Grassley, Baucus seek information from former drug company executive in Avandia case
WASHINGTON — Sens. Chuck Grassley and Max Baucus have asked a former drug company research executive to provide information to the Senate Committee on Finance about attempts to intimidate a prominent independent scientist who voiced concerns about drug safety.
Dr. Tadataka Yamada was formerly the head of research at GlaxoSmithKline. He now heads the Global Health Program at the Bill and Melinda Gates Foundation. Dr. John Buse was a professor of medicine at the University of North Carolina in 1999, when he expressed concerns about the diabetes drug Avandia, which is made by GlaxoSmithKline.
###
Next Article Previous Article
Recent News
- Wyden Statement on Supreme Court Ruling to Restrict Emergency Room Care for Women
- Wyden Statement on HHS Watchdog Report on Lack of Oversight at Youth Residential Treatment Facilities
- Wyden Calls for Action to Stop PBM Middlemen from Flagrantly Flouting Medicare Rules that Protect Pharmacies
- Wyden Statement on Final Rules Promoting Good-Paying Clean Energy Jobs in America
- Wyden Statement at Finance Committee Hearing on Work and Social Security